FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Zydus Pharmaceuticals BENZONATATE Capsules Recall

BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class III
Reported by FDA
Dec 10, 2014
Recall ID
D-0289-2015
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled BENZONATATE Capsules starting Sep 24, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0289-2015 on Dec 10, 2014. Reason: Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules. Status: Terminated.

Why it was recalled

Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

Product description

BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01

Lot numbers, UPCs & expiration codes

Lot #: MM8555, Expiry: 09/14; Lot #: MM6604, Expiry: 09/14; Lot #: MM8551, Expiry: 09/14; Lot #: MM8552, Expiry: 09/14; Lot #: MM8553, Expiry: 09/14; Lot #: MM8554, Expiry: 09/14.

Where it was sold

US Nationwide including Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0289-2015
Classification
Class III
Status
Terminated
Recall initiated
Sep 24, 2014
FDA report date
Dec 10, 2014
Quantity
63,648 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-0289-2015, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
69585
Address
73 Route 31 N
Code information
Lot #: MM8555, Expiry: 09/14; Lot #: MM6604, Expiry: 09/14; Lot #: MM8551, Expiry: 09/14; Lot #: MM8552, Expiry: 09/14; Lot #: MM8553, Expiry: 09/14; Lot #: MM8554, Expiry: 09/14.
Postal code
08534-3601
Report date
Dec 10, 2014
Product type
Drugs
Recall number
D-0289-2015
Classification
Class III
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
63,648 Bottles
Termination date
Jun 21, 2017
Reason for recall
Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.
Voluntary / mandated
Voluntary: Firm initiated
Product description
BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01
Distribution pattern
US Nationwide including Puerto Rico
Recall initiation date
Sep 24, 2014
Initial firm notification
Letter
Center classification date
Dec 3, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0289-2015, published Dec 10, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls